MRKR MARKER THERAPEUTICS INC Contract Awards 8-K Filing 2024 - Grant Award Marker Therapeutics, Inc. announced a $9.5 million grant from CPRIT to support clinical research on MT-601 for pancreatic cancer.Get access to all SEC 8-K filings of the MARKER THERAPEUTICS INC